Literature DB >> 19897032

Comparative study on determination of antioxidant and membrane activities of propofol and its related compounds.

Hironori Tsuchiya1, Takahiro Ueno, Toshiyuki Tanaka, Nobuyasu Matsuura, Maki Mizogami.   

Abstract

Certain anesthetics have been suggested to protect against the pathological states associated with oxidative stress. We compared the antioxidant and membrane activities of propofol (2,6-diisopropylphenol) and its related compounds to address the structure-activity relationship especially in a lipid membrane phase. They were studied for the effects on 1,1-diphenyl-2-picrylhydrazyl radicals, nitro blue tetrazolium reduction by superoxide anions and membrane lipid peroxidation by peroxynitrite, and also for the induced changes in membrane fluidity of liposomes. 2-Isopropylphenols scavenged free radicals with the potency being propofol>2,5-diisopropylphenol>2-isopropylphenol>2,4-diisopropylphenol, but not 3- and 4-isopropylphenols and 1,3- and 1,4-diisopropylbenzenes. The tested compounds showed no significant superoxide dismutase-like effects. Propofol inhibited membrane lipid peroxidation more intensively than 2,5-diisopropylphenol, 2,4-diisopropylphenol and 2-isopropylphenol. Despite structurally resembling antioxidant alpha-tocopherol, 2,6-dimethylphenol was less potent than propofol. Propofol produced 50% inhibition of the lipid peroxidation in unsaturated phosphatidylcholine liposomal membranes and cell-mimetic membranes at 4.0 and 10.1 microM, respectively. Propofol and 2-alkylphenolic compounds interacted with membranes to increase their fluidity with the potency correlating with lipid peroxidation inhibiting activity. The 2-isopropylphenol structure is a requisite for both lipid peroxidation inhibition and membrane fluidity modification. The structure-specific membrane interactivity appears to be one of possible antioxidant mechanisms for propofol. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19897032     DOI: 10.1016/j.ejps.2009.11.001

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  9 in total

1.  Tourniquet-induced ischemia-reperfusion injuries during extremity surgery at children's age: impact of anesthetic chemical structure.

Authors:  Ivana Budic; Dusica Pavlovic; Dusanka Kitic; Gordana Kocic; Tatjana Cvetkovic; Dusica Simic; Tatjana Jevtovic-Stoimenov
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

2.  Characteristic interactivity of landiolol, an ultra-short-acting highly selective β1-blocker, with biomimetic membranes: Comparisons with β1-selective esmolol and non-selective propranolol and alprenolol.

Authors:  Hironori Tsuchiya; Maki Mizogami
Journal:  Front Pharmacol       Date:  2013-12-02       Impact factor: 5.810

3.  Propofol post-conditioning alleviates hepatic ischaemia reperfusion injury via BRG1-mediated Nrf2/HO-1 transcriptional activation in human and mice.

Authors:  Mian Ge; Huixin Chen; Qianqian Zhu; Jun Cai; Chaojin Chen; Dongdong Yuan; Yi Jin; Weifeng Yao; Ziqing Hei
Journal:  J Cell Mol Med       Date:  2017-07-27       Impact factor: 5.310

Review 4. 

Authors:  Hironori Tsuchiya; Maki Mizogami
Journal:  Drug Target Insights       Date:  2020-12-22

Review 5.  A mini-review of the effects of inhalational and intravenous anesthetics on oxidative stress in dogs.

Authors:  Katerina Tomsič; Alenka Nemec Svete
Journal:  Front Vet Sci       Date:  2022-09-12

6.  The influence of propofol-based total intravenous anesthesia on postoperative outcomes in end-stage renal disease patients: A retrospective observation study.

Authors:  Ho Bum Cho; Mun Gyu Kim; Sun Young Park; Sanghoon Song; Youn Sil Jang; Suyeon Park; Hyun Keun Lee; Jae Hwa Yoo; Ji Won Chung; Sang Ho Kim
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

7.  Isoflurane and Propofol Contribute to Increasing the Antioxidant Status of Patients During Minor Elective Surgery: A Randomized Clinical Study.

Authors:  Mariana G Braz; Leandro G Braz; Cristiana M M Freire; Lorena M C Lucio; José R C Braz; Guangwen Tang; Daisy M F Salvadori; Kyung-Jin Yeum
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

8.  Propofol inhibits stromatoxin-1-sensitive voltage-dependent K+ channels in pancreatic β-cells and enhances insulin secretion.

Authors:  Munenori Kusunoki; Mikio Hayashi; Tomohiro Shoji; Takeo Uba; Hiromasa Tanaka; Chisato Sumi; Yoshiyuki Matsuo; Kiichi Hirota
Journal:  PeerJ       Date:  2019-12-02       Impact factor: 2.984

9.  Medium- and long-chain triglyceride propofol reduces the activity of acetyl-coenzyme A carboxylase in hepatic lipid metabolism in HepG2 and Huh7 cells.

Authors:  Li-Yuan Wang; Jing Wu; Ya-Fen Gao; Duo-Mao Lin; Jun Ma
Journal:  Korean J Physiol Pharmacol       Date:  2020-12-20       Impact factor: 2.016

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.